← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial (2025-07-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Triage Test for All Oral DR-TB Regimen (TRiAD Study) (2025-06-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region (2025-06-12) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults (2025-06-04) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Novel Triple-dose Tuberculosis Retreatment Regimen (2025-04-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pulmonary Aspergillosis in Tuberculosis Patients (2025-04-04) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults (2025-02-12) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (2025-02-10) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Evaluating Newly Approved Drugs for Multidrug-resistant TB (2025-02-10) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) (2025-02-03) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis (2025-01-17) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Treatment Shortening of MDR-TB Using Existing and New Drugs (2025-01-03) ♡
• The Imperative Role of Xpert® Mycobacterium Tuberculosis Complex/Resistance to Rifampin (MTB/RIF) in Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis. (2024/12/31) ♡
• Tuberculosis in Poland in 2022. (2024/12/31) ♡
• Formulation and optimisation of bedaquiline nanoemulsions for the potential treatment of multi drug resistant tuberculosis in paediatrics using quality by design. (2024/12/30) ♡
• Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study. (2024/12/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Overcoming Recurrent Isolated Sleep Paralysis: A Case Report of Integrative Management With Yoga, Meditation, and Vitamin D3 Supplementation. (2024/12/30) ♡
• Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages. (2024/12/28) ♡
• Potential of nanopore sequencing for tuberculosis diagnosis and drug resistance detection. (2024/12/28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comorbidities, drug-resistance and length of hospital stay among tuberculosis inpatients in Northeastern China: a retrospective observational study from 2013 to 2021. (2024/12/28) ♡
• Large-scale proteogenomics characterization of microproteins in Mycobacterium tuberculosis. (2024/12/28) ♡
• Indole-containing inhibitors with improved efficacy targeting the gyrase of Mycobacterium tuberculosis. (2024/12/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Lumbar Drug-Resistant Tuberculosis: A Case Report and Review of Literature. (2024/12/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Toward Mycobacterium tuberculosis Virulence Inhibition: Beyond Cell Wall. (2024/12/26) ♡
• Hyperglycemic milieu impairs Vγ9Vδ2 T cell functions in tuberculosis patients and prolongs M.tb negative conversion time. (2024/12/26) ♡
• Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital. (2024/12/25) ♡
• Cost-effectiveness of targeted next-generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysis. (2024/12/24) ♡
• Mapping Drug-Resistant Tuberculosis Treatment Outcomes in Hunan Province, China. (2024/12/24) ♡
• Surveillance for TB drug resistance using routine rapid diagnostic testing data: Methodological development and application in Brazil. (2024/12/23) ♡
• Expanding the Chemical Space of Reverse Fosmidomycin Analogs. (2024/12/23) ♡
• Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort study. (2024/12/22) ♡
• Predictors of treatment delay among drug resistant tuberculosis patients in Uganda. (2024/12/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Association Between Diabetes Mellitus-Tuberculosis and the Generation of Drug Resistance. (2024/12/20) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods. (2024/12/19) ♡
• Structural insights into the enzymatic breakdown of azomycin-derived antibiotics by 2-nitroimdazole hydrolase (NnhA). (2024/12/19) ♡
• Recovery of Mycobacterium tuberculosis Complex Isolates Including Pre-Extensively Drug-Resistant Strains From Cattle at a Slaughterhouse in Chennai, India. (2024/12/19) ♡
• Antimicrobial Resistance Levels of Non-Tuberculous Bacteria Isolates from Sputum of TB Patients in Ghana. (2024/12/18) ♡
• Drug-resistant tuberculosis treatment success predictors in Namibia. (2024/12/18) ♡
• Phenotypic drug resistance and genetic mutations linked to resistance among extrapulmonary tuberculosis patients in Ethiopia: Insights from Whole Genome Sequencing. (2024/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Policy analysis: Key milestones in MDR-TB management over the past decade in South Africa. (2024/12/17) ♡
• Frequency and Predictors of Diabetes Mellitus in Smear-Positive Pulmonary Tuberculosis Patients: A Cross-Sectional Study. (2024/12/16) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques. (2024/12/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Challenges of Multidrug-Resistant Tuberculosis Meningitis: Current Treatments and the Role of Glutathione as an Adjunct Therapy. (2024/12/12) ♡
• Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021. (2024/12/10) ♡
• An Approach to Identifying Single-Nucleotide Mutations Using Noncovalent Associates of Gold Nanoparticles with Fluorescently Labeled Oligonucleotides. (2024/12/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Tuberculosis Caused by Isoniazid-Resistant Strain Was Transmitted from a Woman Undergoing IVFET to Her Fetus by Intrauterine: A Case Report. (2024/12/07) ♡
• Drug-Resistant Tuberculosis Hotspots in Oliver Reginald Tambo District Municipality, Eastern Cape, South Africa. (2024/12/06) ♡
• Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism. (2024/12/03) ♡
• Enhanced Rapid Screening for Multidrug-resistant tuberculosis through combined cardiometabolic and inflammatory indices: a cross-sectional study. (2024/12/02) ♡
• Transmission characteristics in Tuberculosis by WGS: nationwide cross-sectional surveillance in China. (2024/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.